Wall Street Jedi
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Wall Street Jedi
No Result
View All Result
Home Stock

US imposing new export controls on biotech equipment over China concerns

by
January 15, 2025
in Stock
0
US imposing new export controls on biotech equipment over China concerns
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

By David Shepardson

WASHINGTON (Reuters) – The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security concerns tied to artificial intelligence and data science.

Washington has raised concerns that China could use U.S. technology to strengthen military capabilities and help design new weapons through AI. The department said the laboratory equipment could be used for “human performance enhancement, brain-machine interfaces, biologically-inspired synthetic materials, and possibly biological weapons.”

The new export controls, which restrict shipments to China and other countries without a U.S. license, are for high-parameter flow cytometers and certain mass spectrometry equipment, which Commerce said can “generate high-quality, high-content biological data, including that which is suitable for use to facilitate the development of AI and biological design tools.”

This is the latest effort by Washington to restrict U.S. technology to China. On Monday, Commerce moved to further restrict AI chip and technology exports from China aimed at helping the United States maintain its dominant status in AI by controlling it around the world.

U.S. lawmakers have been considering a number of proposals to keep Americans’ personal health and genetic information from foreign adversaries and aim to push U.S. pharmaceutical and biotech companies to lessen their reliance on China for everything from drug ingredient manufacturing to early research.

Last week, U.S. lawmakers called on the Commerce Department to consider restricting the export of U.S. biotechnology to the Chinese military, citing concerns Beijing could weaponize it.

The Chinese Embassy in Washington last week said Beijing “firmly opposes any country’s development, possession or use of biological weapons.”

In August, U.S. lawmakers called on the Food and Drug Administration to ramp up scrutiny of U.S. clinical trials conducted in China, citing the risk of intellectual property theft and the possibility of forced participation of members of China’s Uyghur minority group.

This post appeared first on investing.com
Previous Post

Trump’s new SEC leadership poised to kick start crypto overhaul, sources say

Next Post

US health officials set to ban Red No. 3 food coloring- Bloomberg News

Next Post
US health officials set to ban Red No. 3 food coloring- Bloomberg News

US health officials set to ban Red No. 3 food coloring- Bloomberg News

  • Trending
  • Comments
  • Latest
American creating deepfakes targeting Harris works with Russian intel, documents show

American creating deepfakes targeting Harris works with Russian intel, documents show

October 23, 2024
Cadence raises midpoint of 2024 profit forecast on robust demand from chip designers

Cadence raises midpoint of 2024 profit forecast on robust demand from chip designers

October 28, 2024
Earnings call: Microsoft sees soaring cloud and AI growth in Q1 FY2025

Earnings call: Microsoft sees soaring cloud and AI growth in Q1 FY2025

October 31, 2024
Israel stocks lower at close of trade; TA 35 down 0.23%

Israel stocks lower at close of trade; TA 35 down 0.23%

October 6, 2024
Trump’s tariffs on Brazil could make your coffee even more expensive

Trump’s tariffs on Brazil could make your coffee even more expensive

0
Retailers scramble to move billions in cargo as East Coast dockworkers prepare to strike

Retailers scramble to move billions in cargo as East Coast dockworkers prepare to strike

0
PepsiCo to buy tortilla chip maker Siete Foods for $1.2 billion

PepsiCo to buy tortilla chip maker Siete Foods for $1.2 billion

0
East and Gulf coast ports shut down as thousands of workers go on strike

East and Gulf coast ports shut down as thousands of workers go on strike

0
Trump’s tariffs on Brazil could make your coffee even more expensive

Trump’s tariffs on Brazil could make your coffee even more expensive

July 11, 2025
Italian chocolate giant Ferrero to buy Kellogg’s Froot Loops maker

Italian chocolate giant Ferrero to buy Kellogg’s Froot Loops maker

July 10, 2025
White House accuses Powell of mismanaging Federal Reserve, citing headquarters renovation

White House accuses Powell of mismanaging Federal Reserve, citing headquarters renovation

July 10, 2025
Sports executive charged with bid-rigging in Texas arena project

Sports executive charged with bid-rigging in Texas arena project

July 10, 2025

Recent News

Trump’s tariffs on Brazil could make your coffee even more expensive

Trump’s tariffs on Brazil could make your coffee even more expensive

July 11, 2025
Italian chocolate giant Ferrero to buy Kellogg’s Froot Loops maker

Italian chocolate giant Ferrero to buy Kellogg’s Froot Loops maker

July 10, 2025
White House accuses Powell of mismanaging Federal Reserve, citing headquarters renovation

White House accuses Powell of mismanaging Federal Reserve, citing headquarters renovation

July 10, 2025
Sports executive charged with bid-rigging in Texas arena project

Sports executive charged with bid-rigging in Texas arena project

July 10, 2025

Disclaimer: WallStreetJedi.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 wallstreetjedi.com | All Rights Reserved

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 wallstreetjedi.com | All Rights Reserved